CDH1 and neoplasm: Further comparison of the groups with good or poor prognosis (Table 2) showed significantly higher expression of SSTR2A and E‐cadherin and higher levels of IGF1 at the time of the diagnosis in the good responder group, while the group with poor response presented with significantly larger tumours and younger age.